000			01889 a2200529 4500
005			20250512030516.0
264		0	_c19850402
008			198504s 0 0 eng d
022			_a0022-1899
024	7		_a10.1093/infdis/151.3.407 _2doi
040			_aNLM _beng _cNLM
100	1		_aHilleman, M R
245	0	0	_aNewer directions in vaccine development and utilization. _h[electronic resource]
260			_bThe Journal of infectious diseases _cMar 1985
300			_a407-19 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdjuvants, Immunologic
650	0	4	_aAntibodies, Monoclonal
650	0	4	_aAntibodies, Viral _xbiosynthesis
650	0	4	_aBacterial Vaccines _ximmunology
650	0	4	_aCarcinoma, Hepatocellular
650	0	4	_aCell Line
650	0	4	_aDNA, Recombinant
650	0	4	_aGenes, Viral
650	0	4	_aHepatitis A _xprevention & control
650	0	4	_aHepatitis B _xprevention & control
650	0	4	_aHepatitis B Core Antigens _ximmunology
650	0	4	_aHepatitis B Surface Antigens _xgenetics
650	0	4	_aHepatitis B Vaccines
650	0	4	_aHepatitis B e Antigens _ximmunology
650	0	4	_aHepatitis B virus _ximmunology
650	0	4	_aHepatovirus _ximmunology
650	0	4	_aHerpesviridae _ximmunology
650	0	4	_aHerpesvirus 3, Human _ximmunology
650	0	4	_aHumans
650	0	4	_aLiver Neoplasms
650	0	4	_aParasitic Diseases _xprevention & control
650	0	4	_aSimplexvirus _ximmunology
650	0	4	_aVaccination
650	0	4	_aVaccines _ximmunology
650	0	4	_aVaccines, Attenuated
650	0	4	_aVaccinia virus _xgenetics
650	0	4	_aViral Hepatitis Vaccines _ximmunology
650	0	4	_aViral Vaccines _ximmunology
773	0		_tThe Journal of infectious diseases _gvol. 151 _gno. 3 _gp. 407-19
856	4	0	_uhttps://doi.org/10.1093/infdis/151.3.407 _zAvailable from publisher's website
999			_c2988774 _d2988774